Skip to main content
Log in

A New Strategy for Enhancing the Stability of Lyophilized Protein: The Effect of the Reconstitution Medium on Keratinocyte Growth Factor

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Protein stabilization during lyophilization has previously focused on optimization of the formulation as well as the freezing and dehydration process parameters. However, the effect of the reconstitution medium has been largely neglected. We have investigated its effect on aggregate formation using recombinant keratinocyte growth factor (KGF).

Methods. The protein was lyophilized under suboptimal conditions to induce aggregation and precipitation upon reconstitution with water. A series of additives were examined by UV spectrophotometry and size exclusion chromatography (SEC-HPLC) for their effects on decreasing the degree of KGF aggregation and precipitation by the increase in recovery of soluble monomer.

Results. Several additives resulted in a significant reduction of aggregation, including sulfated polysaccharides, surfactants, polyphosphates, and amino acids. A similar effect was achieved by adjusting the ionic strength of the reconstitution medium. SEC-HPLC indicated that the amount of soluble monomer was also increased by these additives suggesting that the recovery of the soluble protein correlates with the native, monomeric protein.

Conclusions. These results suggest that optimization of reconstitution conditions will be a useful methodology for increasing the recovery of soluble, active proteins and that for KGF, the recovery of the soluble protein correlates with the native, monomeric form.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. C. Manning, K. Patel, and R. T. Borchardt. Stability of protein pharmaceuticals. Pharm. Res. 6:903–918 (1989).

    Google Scholar 

  2. M. J. Pikal. Freeze-drying of proteins. II. Formulation selection. BioPharm. 3:26–30 (1990).

    Google Scholar 

  3. T. Arakawa, J. F. Carpenter, Y. A. Kita, and J. H. Crowe. Basis for toxicity of certain cryoprotectants. A hypothesis. Cryobiology 27:401–415 (1990).

    Google Scholar 

  4. J. F. Carpenter and J. H. Crowe. An infrared spectroscopic study of interactions of carbohydrates with dried proteins. Biochemistry 28:3916–3922 (1988).

    Google Scholar 

  5. T. Chen. Formulation concerns of protein drugs. Drug Dev. Ind. Pharm. 18:1311–1354 (1992).

    Google Scholar 

  6. A. Rupley, E. Gratton, and G. Careri. Water and globular proteins. Trends Biochem. Sci. 8:18–22 (1983).

    Google Scholar 

  7. T. Tagaki. Application of low-angle laser light scattering detection in the field of biochemistry. J. Chromatorgr. 506:409–416 (1990).

    Google Scholar 

  8. J. S. Rubin, H. Osada, P. W. Finch, W. G. Taylor, S. Rudickoff, and S. A. Aaronson. Purification and characterization of a newly identification growth factor specific for epithelia cells. Pro. Natl. Acad. Sci. USA 86:802–806 (1988).

    Google Scholar 

  9. P. W. Finch, J. S. Rubin, T. Miki, D. Ron, and S. A. Aaronson. Human KGF is FGF-related with properties of a paracrine effector of epithelial cells. Science 245:752–755 (1989).

    Google Scholar 

  10. S. A. Aaronson, J. S. Rubin, P. W. Finch, J. Wong, C. Marchese, J. Falco, W. G. Taylor, and M. H. Kraus. Growth factor-regulated pathways in epithelial cell proliferation. Am. Rev. Respir. Dis. 142:S7–S10 (1990).

    Google Scholar 

  11. B. L. Chen, T. Arakawa, C. F. Morris, W. C. Kenney, C. M. Wells, and C. G. Pitt. Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization. Pharm. Res. 11:1582–1589 (1994).

    Google Scholar 

  12. K. Tsai, D. B. Volkin, J. M. Dabora, K. C. Thompson, M. W. Bruner, J. O. Gress, B. Matuszewska, M. Keogan, J. V. Bondi, and C. R. Middaugh. Formulation design of acidic fibroblast growth factor. Pharm. Res. 10:649–659 (1993).

    Google Scholar 

  13. D. Ron, D. P. Bottaro, P. W. Finch, D. Morris, J. S. Rubin, and S. A. Aaronson. Expression of biological active recombinant keratinocyte growth factor. J. Biol. Chem. 268:2984–2988 (1993).

    Google Scholar 

  14. J. H. Crowe, L. M. Crowe, J. F. Carpenter, and C. A. Wistrom. Stabilization of dry phopholipid bilayers and proteins by sugars. Biochem. J. 242:1–10 (1987).

    Google Scholar 

  15. M. J. Pikal, K. M. Dellerman, M. L. Roy, and R. M. Riggin. The effects of formulation variables on the stability of freeze dried human growth hormone. Pharm Res. 8:427–436 (1991).

    Google Scholar 

  16. T. Tamiya, N. Okahashi, R. Sakuma, T. Aoyama, T. Akahane, and J. J. Matsumoto. Freeze denaturation of enzymes and its prevention with additives. Cryobiology. 22:446–456 (1985).

    Google Scholar 

  17. S. Yoshioka, Y. Aso, K. Izutsu, and T. Terao. Aggregates formed during storage of β-galactosidase in solution and in the freeze-dried state. Pharm. Res. 10:687–691 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, M.Z., Wen, J., Arakawa, T. et al. A New Strategy for Enhancing the Stability of Lyophilized Protein: The Effect of the Reconstitution Medium on Keratinocyte Growth Factor. Pharm Res 12, 1447–1452 (1995). https://doi.org/10.1023/A:1016219000963

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016219000963

Navigation